Literature DB >> 11177710

Angiotensin, inflammation, hypertension, and cardiovascular disease.

F C Luft1.   

Abstract

We are used to thinking of angiotensin (Ang) II as a regulatory hormone that stimulates constriction of vascular smooth muscle cells, aldosterone release from the adrenal gland, and sodium reabsorption in the renal tubule. We have also become accustomed to understanding that Ang II may be formed and may act locally as a chemokine that induces tyrosine phosphorylation, cell growth, hypertrophy, and differentiation. Viewing Ang II as an inflammatory molecule is stranger still. Nevertheless, recent evidence shows that Ang II is important in stimulating the production of reactive oxygen species and the activation of ancient inflammatory mechanisms. The nuclear factor kappaB (NF-kappaB) is pivotal to these processes. Activation of NF-kappaB stimulates the expression of a gene menagerie that is important to chemoattraction, expression of surface adhesion molecules, coagulation, and inflammation. In addition, Ang II has been shown to regulate cellular immune responses. It stimulates the proliferation of lymphocytes and contributes to their activation via calcineurin-related pathways. Knowledge of these mechanisms may provide additional therapeutic avenues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11177710     DOI: 10.1007/s11906-001-0082-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  52 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases.

Authors:  B C Berk
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

Review 3.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

Authors:  T O Chan; S E Rittenhouse; P N Tsichlis
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

4.  Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

Authors:  G Nickenig; A T Bäumer; Y Temur; D Kebben; F Jockenhövel; M Böhm
Journal:  Circulation       Date:  1999-11-23       Impact factor: 29.690

5.  Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.

Authors:  J D Luo; W W Zhang; G P Zhang; J X Guan; X Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-11       Impact factor: 2.557

Review 6.  Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.

Authors:  K Irani
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

7.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Authors:  D N Müller; E M Mervaala; R Dechend; A Fiebeler; J K Park; F Schmidt; J Theuer; V Breu; N Mackman; T Luther; W Schneider; D Gulba; D Ganten; H Haller; F C Luft
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.

Authors:  C Viedt; U Soto; H I Krieger-Brauer; J Fei; C Elsing; W Kübler; J Kreuzer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

9.  Transcription factors modulating angiotensinogen gene expression in hepatocytes.

Authors:  A R Brasier; J Li; A Copland
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

10.  Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator.

Authors:  A R Brasier; J Li; K A Wimbish
Journal:  Hypertension       Date:  1996-04       Impact factor: 10.190

View more
  12 in total

1.  LDL cholesterol angiotensin II interactions in atherosclerosis.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2001-05       Impact factor: 4.599

2.  Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.

Authors:  Zhengrong Guan; Barry S Fuller; Tatsuo Yamamoto; Anthony K Cook; Jennifer S Pollock; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03

3.  Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Authors:  Jorge L Gamboa; Mias Pretorius; Deanna R Todd-Tzanetos; James M Luther; Chang Yu; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2011-12-08       Impact factor: 10.121

4.  The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension.

Authors:  Ji Hyun Kim; Su Jin Oh; Jung Min Lee; Eun Gyoung Hong; Jae Myung Yu; Kyung Ah Han; Kyung Wan Min; Hyun Shik Son; Sang Ah Chang
Journal:  Diabetes Metab J       Date:  2011-06-30       Impact factor: 5.376

Review 5.  Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.

Authors:  Liang Xiao; David M Patrick; Luul A Aden; Annet Kirabo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-29       Impact factor: 3.072

6.  Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction.

Authors:  Arul Veerappan; Alicia C Reid; Racha Estephan; Nathan O'Connor; Maria Thadani-Mulero; Mariselis Salazar-Rodriguez; Roberto Levi; Randi B Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

7.  Inflammation in lone atrial fibrillation.

Authors:  Shu-Yuan Yao; Jian-Min Chu; Ke-Ping Chen; Min Tang; Pi-Hua Fang; Fang-Zheng Wang; Shu Zhang
Journal:  Clin Cardiol       Date:  2009-02       Impact factor: 2.882

Review 8.  Positioning of inflammatory biomarkers in the heart failure landscape.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  J Cardiovasc Transl Res       Date:  2013-05-11       Impact factor: 4.132

9.  Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness.

Authors:  Francesca Kum; Janaka Karalliedde
Journal:  Integr Blood Press Control       Date:  2010-06-04

10.  Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension.

Authors:  Haibo Xu; Elizabeth B Oliveira-Sales; Fiona McBride; Beihui Liu; James Hewinson; Marie Toward; Emma B Hendy; Delyth Graham; Anna F Dominiczak; Monica Giannotta; Hidefumi Waki; Raimondo Ascione; Julian F R Paton; Sergey Kasparov
Journal:  Cardiovasc Res       Date:  2012-08-22       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.